Digital Health Technologies for Clinical Research
Ametris (formerly ActiGraph) (actigraphcorp.com) scores 71 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Technology brands, in the 25th percentile of 11909 Healthcare brands.
Ametris, formerly known as ActiGraph and now part of Signant Health, is a digital health technology company serving the clinical research industry. It provides wearable-based, objective, real-world digital measures of patient function to support drug development. The company combines wearable technology with therapeutic expertise, focusing on areas such as neuromuscular disorders and oncology, to help pharmaceutical and biotech companies strengthen clinical trial evidence and streamline drug development processes.
| Brand Name | Ametris (formerly ActiGraph) |
|---|---|
| Domain | actigraphcorp.com |
| Industry | Healthcare, Technology |
| Parent Company / Owner | Signant Health |
| Main Competitors | Clario (90/100), Medidata Solutions (89/100), Koneksa Health (73/100), VivoSense (73/100), Biofourmis (79/100), Huma Therapeutics (84/100) |
Moz Domain Authority 45/100 vs category average 41 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #3,274,519 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "We" (Meta description too short (1 words). OG description present but brief) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:description, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, HubSpot.
Social footprint: verified profiles on LinkedIn, Instagram; no detected presence on Facebook, X (Twitter), YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is Ametris (formerly ActiGraph)?", Claude could identify the brand as of September 2026. ActiGraph, now rebranded as Ametris, is a company known for developing wearable medical-grade activity monitors and accelerometers used in clinical research to objectively measure physical activity, sleep, and behavior. Their devices are widely used in pharmaceutical trials and a Best known for Making research-grade wearable activity monitors (accelerometers) used as clinical trial endpoints.
When asked "Best brands similar to Ametris (formerly ActiGraph)?", Claude would recommend Ametris (formerly ActiGraph) as of September 2026. ActiGraph/Ametris is a well-established name in clinical-grade wearable activity monitoring for research and trials, so it's worth mentioning alongside other digital biomarker or wearable research device companies.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Ametris (formerly ActiGraph)'s main competitors in Healthcare: Clario (90/100), Medidata Solutions (89/100), Koneksa Health (73/100), VivoSense (73/100), Biofourmis (79/100).
Sources: Brand Analyzer scan
Ametris (formerly ActiGraph) has low AI-search visibility, scoring 24/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 29, recommendation 60). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Ametris (formerly ActiGraph) scores 60/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Ametris (formerly ActiGraph) can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Ametris, formerly ActiGraph, is a digital health technology company now operating as part of Signant Health. It specializes in providing objective, real-world digital measures of patient function for use in clinical trials, combining wearable device technology with therapeutic area expertise to support pharmaceutical and biotech drug development programs.
Ametris is used by pharmaceutical and biotech companies, clinical researchers, and drug development teams seeking advanced digital measurement tools to support clinical trials. These users rely on Ametris's wearable technology and therapeutic expertise to obtain objective, real-world data on patient function during drug development programs.
Ametris (formerly ActiGraph) scores 24/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Ametris (formerly ActiGraph) has a weak AI-visibility profile at 24/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (60/100) and its weakest is visibility (0/100). It benefits from a global traffic rank of #3,274,519 (Tranco), a Moz Domain Authority of 45/100 and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and thin schema.org structured data. In a live check, Claude could already identify Ametris (formerly ActiGraph) from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Ametris (formerly ActiGraph): Access TeleCare (71/100), Access TeleCare (71/100), Adcock Ingram (71/100), Aegros (71/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.